(TheNewswire)


MISSISSAUGA, Ontario TheNewswire – March 10, 2021 Sire Bioscience Inc. (CSE:SIRE) (CNSX:SIRE.CN) (OTC:BLLXF) (FSE:BR1B) (“Sire” or the “Company”) announces that, in response to the ongoing global COVID-19 pandemic, it will host its annual general and special meeting of shareholders (the “ Meeting ”) by teleconference only, at 11:00 am Pacific Standard Time on Friday, April 9, 2021.

The Company made the decision to hold the Meeting by teleconference after considering Provincial and Federal guidance regarding public gatherings, and to proactively protect the health and wellbeing of the Company’s shareholders, officers, directors and service providers that will participate in the Meeting.

The Company encourages its shareholders to vote their common shares before the proxy cut-off date of Wednesday, April 7, 2021 at 11 am PST and reminds its shareholders that no votes will be accepted at the Meeting.

Shareholders who wish to attend the Meeting can find the details to attend below.

Conference Dial-in Number: 1-888-299-2873 (toll free in Canada) or 1-888-585-9008 (toll-free in the USA)

Conference Room #: 448-444-850

Dial in for any other countries, please contact the Company at 604.737.2303 prior to the Meeting date for dial in particulars.

How to Vote:

  • – Registered shareholders of the Company will be able to vote their common shares online at www.investorvote.com or by telephone (1-866-732-VOTE (8683) (Toll Free)).  The Registered shareholders will require their control number which can be found on their proxy form that will be mailed out to the Company’s shareholders on or before Friday, March 19, 2021.

    – Non-objecting beneficial (“ NOBO ”) shareholders of the Company will be able to vote common shares online at www.investorvote.com or by telephone (1-866-734-VOTE (8683) (Toll Free)).  The NOBO holders will require their control number which can be found on their voting instruction form.

    – Objecting beneficial shareholders of the Company must contact their broker directly to obtain their proxy form to vote their common shares.

About Sire Bioscience Inc.

Sire is headquartered in Mississauga, Ontario, and is managed by a group of successful entrepreneurs who have extensive experience in the areas of consumer-packaged goods, manufacturing, logistics, and distribution. Sire is a CPG life science company focused on the plant-based foods and supplements industry.

For additional information contact:

Sire Bioscience Inc.
Brian Polla, CEO
T:  416.669.9392
E: ir@sirebioscience.com
W: sirebioscience.com
Socials: @sirebioscience

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2021 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.

Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.

Keep reading... Show less

New findings suggest the COVID-19 pandemic, combined with expanded state legalization, has attracted new consumers to the category and accelerated cannabis acceptance and adoption.

  • YouGov study indicates the number of current cannabis consumers has increased 56% within just two years compared to the 16% of Americans who reported current consumption in 2018.
  • 23% of current consumers say they tried cannabis for the first time within the past year.
  • More than half of cannabis consumers say they will purchase or try a new product or format this 420, indicating that the holiday is becoming increasingly focused on exploration and trial.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, released the results of a survey today showing one in four Americans currently consume cannabis, reporting they’ve tried some form of cannabis within the past twelve months. That’s a significant increase since 2018* when just 16% of U.S. adults reported current consumption, representing a 56% increase in just two years. What’s more, 23% of current cannabis consumers say they tried cannabis for the first time over the past year, suggesting the COVID-19 pandemic, combined with expanded state legalization, has rapidly accelerated cannabis acceptance and adoption in America.

Keep reading... Show less

Acquires Three Operating Dispensaries in Northeast Pennsylvania

Purchase price represents a mid-single digit multiple of KCR’s expected 2021 EBITDA

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) subsidiary Lyfted Farms has much to commemorate this 420 (April 20th) known as the international day of celebration and celebratory consumption of cannabis.

The Company fulfilled an impressive $100k initial order of 25 pounds of premium indoor exotic cannabis flower and concentrates that hit the shelves of 14 famed STIIIZY retail locations throughout California last week, just ahead of the biggest day in cannabis counterculture.

Keep reading... Show less

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) (“Curaleaf” or the “Company”) a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2021 after market close on May 10, 2021 .

Management will host a conference call and audio webcast that evening at 5:00 p.m. ET consisting of prepared remarks followed by a question and answer session related to the Company’s operational and financial highlights.

Keep reading... Show less